Do not stop or change diabetes medicines without clinical guidance, especially if insulin or a sulfonylurea is part of your plan
The FDA prescribing information specifically warns about the risk of acute kidney injury in patients who experience severe gastrointestinal adverse reactions
Additional claims involve vision-related injuries that patients say developed after sustained use of GLP-1 drugs
This mechanism enhances focus, concentration, and physical performance
Advanced considerations, such as handling peptide modifications and employing analytical verification, further enhance the reliability of peptide reconstitution
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations